The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study

Completed · Phase 3

Conditions studied: Carcinoma, Transitional Cell, Transitional Cell Carcinoma of Renal Pelvis

In brief

The study is investigating the ability of UroGen's UGN-101 to treat urothelial carcinoma tumors from the upper urinary tract.

Key facts

Study ID
NCT02793128
Run by
UroGen Pharma Ltd.
People needed
71
Starts
2017-04-04
Expected to finish
2020-03-05
Last updated by the study team
2020-12-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.